nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—Infection—Carboplatin—esophageal cancer	0.00563	0.0103	CcSEcCtD
Cilostazol—Neck stiffness—Methotrexate—esophageal cancer	0.00537	0.00983	CcSEcCtD
Cilostazol—Interstitial pneumonia—Methotrexate—esophageal cancer	0.00529	0.00968	CcSEcCtD
Cilostazol—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00524	0.00959	CcSEcCtD
Cilostazol—Furuncle—Methotrexate—esophageal cancer	0.00521	0.00954	CcSEcCtD
Cilostazol—Hyperuricaemia—Cisplatin—esophageal cancer	0.00502	0.00919	CcSEcCtD
Cilostazol—Neuralgia—Capecitabine—esophageal cancer	0.00494	0.00905	CcSEcCtD
Cilostazol—Haematemesis—Capecitabine—esophageal cancer	0.00494	0.00905	CcSEcCtD
Cilostazol—Nuchal rigidity—Methotrexate—esophageal cancer	0.00492	0.00902	CcSEcCtD
Cilostazol—Torsade de pointes—Capecitabine—esophageal cancer	0.00489	0.00896	CcSEcCtD
Cilostazol—Thrombosis—Capecitabine—esophageal cancer	0.00485	0.00888	CcSEcCtD
Cilostazol—Pain—Carboplatin—esophageal cancer	0.00484	0.00887	CcSEcCtD
Cilostazol—Blood uric acid increased—Cisplatin—esophageal cancer	0.00474	0.00868	CcSEcCtD
Cilostazol—Tongue disorder—Capecitabine—esophageal cancer	0.00472	0.00864	CcSEcCtD
Cilostazol—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00464	0.00849	CcSEcCtD
Cilostazol—Haemoptysis—Capecitabine—esophageal cancer	0.00464	0.00849	CcSEcCtD
Cilostazol—Body temperature increased—Carboplatin—esophageal cancer	0.00448	0.0082	CcSEcCtD
Cilostazol—Fluid retention—Cisplatin—esophageal cancer	0.00442	0.00809	CcSEcCtD
Cilostazol—Hyperaesthesia—Capecitabine—esophageal cancer	0.00437	0.00801	CcSEcCtD
Cilostazol—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00427	0.00782	CcSEcCtD
Cilostazol—Eruption—Methotrexate—esophageal cancer	0.00415	0.00761	CcSEcCtD
Cilostazol—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00383	0.00701	CcSEcCtD
Cilostazol—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.0038	0.00696	CcSEcCtD
Cilostazol—Rectal haemorrhage—Capecitabine—esophageal cancer	0.0038	0.00696	CcSEcCtD
Cilostazol—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00373	0.00682	CcSEcCtD
Cilostazol—Haematemesis—Methotrexate—esophageal cancer	0.00368	0.00673	CcSEcCtD
Cilostazol—Interstitial lung disease—Methotrexate—esophageal cancer	0.00361	0.00661	CcSEcCtD
Cilostazol—Bone pain—Capecitabine—esophageal cancer	0.00358	0.00656	CcSEcCtD
Cilostazol—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00345	0.00632	CcSEcCtD
Cilostazol—Blood pressure increased—Capecitabine—esophageal cancer	0.00343	0.00629	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00338	0.00619	CcSEcCtD
Cilostazol—Melaena—Capecitabine—esophageal cancer	0.00335	0.00614	CcSEcCtD
Cilostazol—Colitis—Capecitabine—esophageal cancer	0.0033	0.00603	CcSEcCtD
Cilostazol—Face oedema—Cisplatin—esophageal cancer	0.00326	0.00598	CcSEcCtD
Cilostazol—Fluid retention—Capecitabine—esophageal cancer	0.00326	0.00597	CcSEcCtD
Cilostazol—Blood creatinine increased—Cisplatin—esophageal cancer	0.00317	0.0058	CcSEcCtD
Cilostazol—Oesophagitis—Capecitabine—esophageal cancer	0.00314	0.00574	CcSEcCtD
Cilostazol—Ecchymosis—Capecitabine—esophageal cancer	0.0031	0.00568	CcSEcCtD
Cilostazol—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00309	0.00565	CcSEcCtD
Cilostazol—Ear pain—Capecitabine—esophageal cancer	0.00292	0.00535	CcSEcCtD
Cilostazol—Diabetes mellitus—Capecitabine—esophageal cancer	0.00286	0.00525	CcSEcCtD
Cilostazol—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00285	0.00522	CcSEcCtD
Cilostazol—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00285	0.00522	CcSEcCtD
Cilostazol—Gastroenteritis—Capecitabine—esophageal cancer	0.00281	0.00515	CcSEcCtD
Cilostazol—Vascular purpura—Capecitabine—esophageal cancer	0.00278	0.0051	CcSEcCtD
Cilostazol—Pancytopenia—Cisplatin—esophageal cancer	0.00277	0.00508	CcSEcCtD
Cilostazol—Hyperuricaemia—Methotrexate—esophageal cancer	0.00275	0.00504	CcSEcCtD
Cilostazol—Hot flush—Capecitabine—esophageal cancer	0.00266	0.00488	CcSEcCtD
Cilostazol—Menopausal symptoms—Capecitabine—esophageal cancer	0.00264	0.00484	CcSEcCtD
Cilostazol—Atrial fibrillation—Capecitabine—esophageal cancer	0.00263	0.00481	CcSEcCtD
Cilostazol—Blood uric acid increased—Methotrexate—esophageal cancer	0.0026	0.00476	CcSEcCtD
Cilostazol—Purpura—Capecitabine—esophageal cancer	0.00258	0.00473	CcSEcCtD
Cilostazol—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00257	0.0047	CcSEcCtD
Cilostazol—Arthritis—Capecitabine—esophageal cancer	0.00256	0.00469	CcSEcCtD
Cilostazol—Vaginal inflammation—Methotrexate—esophageal cancer	0.00255	0.00468	CcSEcCtD
Cilostazol—Myocardial infarction—Cisplatin—esophageal cancer	0.00255	0.00468	CcSEcCtD
Cilostazol—Cardiac failure—Capecitabine—esophageal cancer	0.00255	0.00468	CcSEcCtD
Cilostazol—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00254	0.00466	CcSEcCtD
Cilostazol—Conjunctivitis—Cisplatin—esophageal cancer	0.00253	0.00464	CcSEcCtD
Cilostazol—Cystitis noninfective—Methotrexate—esophageal cancer	0.0025	0.00457	CcSEcCtD
Cilostazol—Melaena—Methotrexate—esophageal cancer	0.0025	0.00457	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00249	0.00456	CcSEcCtD
Cilostazol—Diplopia—Capecitabine—esophageal cancer	0.00249	0.00456	CcSEcCtD
Cilostazol—Cystitis—Methotrexate—esophageal cancer	0.00247	0.00452	CcSEcCtD
Cilostazol—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00246	0.00451	CcSEcCtD
Cilostazol—Vaginal infection—Methotrexate—esophageal cancer	0.00241	0.00442	CcSEcCtD
Cilostazol—Face oedema—Capecitabine—esophageal cancer	0.00241	0.0044	CcSEcCtD
Cilostazol—Aplastic anaemia—Methotrexate—esophageal cancer	0.0024	0.00439	CcSEcCtD
Cilostazol—Cardiac arrest—Capecitabine—esophageal cancer	0.00237	0.00434	CcSEcCtD
Cilostazol—Blood creatinine increased—Capecitabine—esophageal cancer	0.00233	0.00427	CcSEcCtD
Cilostazol—Ecchymosis—Methotrexate—esophageal cancer	0.00231	0.00423	CcSEcCtD
Cilostazol—Bladder pain—Methotrexate—esophageal cancer	0.00231	0.00423	CcSEcCtD
Cilostazol—Liver function test abnormal—Capecitabine—esophageal cancer	0.0023	0.00421	CcSEcCtD
Cilostazol—Dry skin—Capecitabine—esophageal cancer	0.00228	0.00418	CcSEcCtD
Cilostazol—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00228	0.00417	CcSEcCtD
Cilostazol—Gastritis—Capecitabine—esophageal cancer	0.0022	0.00404	CcSEcCtD
Cilostazol—Tinnitus—Cisplatin—esophageal cancer	0.00218	0.00399	CcSEcCtD
Cilostazol—Cardiac disorder—Cisplatin—esophageal cancer	0.00217	0.00397	CcSEcCtD
Cilostazol—Influenza—Capecitabine—esophageal cancer	0.00215	0.00394	CcSEcCtD
Cilostazol—Asthma—Capecitabine—esophageal cancer	0.00215	0.00394	CcSEcCtD
Cilostazol—Diabetes mellitus—Methotrexate—esophageal cancer	0.00213	0.0039	CcSEcCtD
Cilostazol—Mediastinal disorder—Cisplatin—esophageal cancer	0.00211	0.00386	CcSEcCtD
Cilostazol—Angina pectoris—Capecitabine—esophageal cancer	0.0021	0.00384	CcSEcCtD
Cilostazol—Bronchitis—Capecitabine—esophageal cancer	0.00207	0.00379	CcSEcCtD
Cilostazol—Pancytopenia—Capecitabine—esophageal cancer	0.00204	0.00374	CcSEcCtD
Cilostazol—Flatulence—Cisplatin—esophageal cancer	0.00201	0.00367	CcSEcCtD
Cilostazol—Muscle spasms—Cisplatin—esophageal cancer	0.00196	0.00358	CcSEcCtD
Cilostazol—Pneumonia—Capecitabine—esophageal cancer	0.00193	0.00354	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0019	0.00349	CcSEcCtD
Cilostazol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00189	0.00347	CcSEcCtD
Cilostazol—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00189	0.00347	CcSEcCtD
Cilostazol—Ill-defined disorder—Cisplatin—esophageal cancer	0.00189	0.00346	CcSEcCtD
Cilostazol—Myocardial infarction—Capecitabine—esophageal cancer	0.00188	0.00345	CcSEcCtD
Cilostazol—Anaemia—Cisplatin—esophageal cancer	0.00188	0.00345	CcSEcCtD
Cilostazol—Jaundice—Capecitabine—esophageal cancer	0.00187	0.00343	CcSEcCtD
Cilostazol—Urinary tract infection—Capecitabine—esophageal cancer	0.00187	0.00342	CcSEcCtD
Cilostazol—Conjunctivitis—Capecitabine—esophageal cancer	0.00187	0.00342	CcSEcCtD
Cilostazol—Malaise—Cisplatin—esophageal cancer	0.00184	0.00336	CcSEcCtD
Cilostazol—Haematuria—Capecitabine—esophageal cancer	0.00183	0.00335	CcSEcCtD
Cilostazol—Leukopenia—Cisplatin—esophageal cancer	0.00182	0.00334	CcSEcCtD
Cilostazol—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00182	0.00333	CcSEcCtD
Cilostazol—Epistaxis—Capecitabine—esophageal cancer	0.00181	0.00332	CcSEcCtD
Cilostazol—Agranulocytosis—Capecitabine—esophageal cancer	0.00179	0.00328	CcSEcCtD
Cilostazol—Myalgia—Cisplatin—esophageal cancer	0.00173	0.00317	CcSEcCtD
Cilostazol—Haemoglobin—Capecitabine—esophageal cancer	0.00173	0.00317	CcSEcCtD
Cilostazol—Rhinitis—Capecitabine—esophageal cancer	0.00173	0.00316	CcSEcCtD
Cilostazol—Anxiety—Cisplatin—esophageal cancer	0.00173	0.00316	CcSEcCtD
Cilostazol—Haemorrhage—Capecitabine—esophageal cancer	0.00172	0.00316	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00172	0.00315	CcSEcCtD
Cilostazol—Hypoaesthesia—Capecitabine—esophageal cancer	0.00171	0.00314	CcSEcCtD
Cilostazol—Liver function test abnormal—Methotrexate—esophageal cancer	0.00171	0.00314	CcSEcCtD
Cilostazol—Discomfort—Cisplatin—esophageal cancer	0.00171	0.00314	CcSEcCtD
Cilostazol—Pharyngitis—Capecitabine—esophageal cancer	0.00171	0.00313	CcSEcCtD
Cilostazol—Oedema peripheral—Capecitabine—esophageal cancer	0.0017	0.00311	CcSEcCtD
Cilostazol—Oedema—Cisplatin—esophageal cancer	0.00166	0.00304	CcSEcCtD
Cilostazol—Infection—Cisplatin—esophageal cancer	0.00165	0.00302	CcSEcCtD
Cilostazol—Erythema multiforme—Capecitabine—esophageal cancer	0.00163	0.00298	CcSEcCtD
Cilostazol—Nervous system disorder—Cisplatin—esophageal cancer	0.00163	0.00298	CcSEcCtD
Cilostazol—Thrombocytopenia—Cisplatin—esophageal cancer	0.00163	0.00298	CcSEcCtD
Cilostazol—Tachycardia—Cisplatin—esophageal cancer	0.00162	0.00297	CcSEcCtD
Cilostazol—Skin disorder—Cisplatin—esophageal cancer	0.00161	0.00295	CcSEcCtD
Cilostazol—Tinnitus—Capecitabine—esophageal cancer	0.00161	0.00294	CcSEcCtD
Cilostazol—Asthma—Methotrexate—esophageal cancer	0.0016	0.00294	CcSEcCtD
Cilostazol—Cardiac disorder—Capecitabine—esophageal cancer	0.0016	0.00293	CcSEcCtD
Cilostazol—Anorexia—Cisplatin—esophageal cancer	0.00158	0.0029	CcSEcCtD
Cilostazol—Angiopathy—Capecitabine—esophageal cancer	0.00156	0.00286	CcSEcCtD
Cilostazol—Mediastinal disorder—Capecitabine—esophageal cancer	0.00155	0.00284	CcSEcCtD
Cilostazol—Hypotension—Cisplatin—esophageal cancer	0.00155	0.00284	CcSEcCtD
Cilostazol—Chills—Capecitabine—esophageal cancer	0.00155	0.00283	CcSEcCtD
Cilostazol—Pancytopenia—Methotrexate—esophageal cancer	0.00152	0.00279	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00151	0.00277	CcSEcCtD
Cilostazol—Paraesthesia—Cisplatin—esophageal cancer	0.00149	0.00273	CcSEcCtD
Cilostazol—Dyspnoea—Cisplatin—esophageal cancer	0.00148	0.00271	CcSEcCtD
Cilostazol—Flatulence—Capecitabine—esophageal cancer	0.00148	0.00271	CcSEcCtD
Cilostazol—Back pain—Capecitabine—esophageal cancer	0.00145	0.00266	CcSEcCtD
Cilostazol—Decreased appetite—Cisplatin—esophageal cancer	0.00144	0.00264	CcSEcCtD
Cilostazol—Muscle spasms—Capecitabine—esophageal cancer	0.00144	0.00264	CcSEcCtD
Cilostazol—Pneumonia—Methotrexate—esophageal cancer	0.00144	0.00263	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00143	0.00263	CcSEcCtD
Cilostazol—Pain—Cisplatin—esophageal cancer	0.00142	0.0026	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00142	0.00259	CcSEcCtD
Cilostazol—Ill-defined disorder—Capecitabine—esophageal cancer	0.00139	0.00255	CcSEcCtD
Cilostazol—Conjunctivitis—Methotrexate—esophageal cancer	0.00139	0.00254	CcSEcCtD
Cilostazol—Anaemia—Capecitabine—esophageal cancer	0.00139	0.00254	CcSEcCtD
Cilostazol—Feeling abnormal—Cisplatin—esophageal cancer	0.00137	0.00251	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—esophageal cancer	0.00136	0.0025	CcSEcCtD
Cilostazol—Malaise—Capecitabine—esophageal cancer	0.00135	0.00248	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00135	0.00248	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—esophageal cancer	0.00135	0.00247	CcSEcCtD
Cilostazol—Vertigo—Capecitabine—esophageal cancer	0.00135	0.00247	CcSEcCtD
Cilostazol—Syncope—Capecitabine—esophageal cancer	0.00135	0.00246	CcSEcCtD
Cilostazol—Leukopenia—Capecitabine—esophageal cancer	0.00134	0.00246	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—esophageal cancer	0.00133	0.00244	CcSEcCtD
Cilostazol—Palpitations—Capecitabine—esophageal cancer	0.00133	0.00243	CcSEcCtD
Cilostazol—Loss of consciousness—Capecitabine—esophageal cancer	0.00132	0.00241	CcSEcCtD
Cilostazol—Body temperature increased—Cisplatin—esophageal cancer	0.00131	0.0024	CcSEcCtD
Cilostazol—Cough—Capecitabine—esophageal cancer	0.00131	0.0024	CcSEcCtD
Cilostazol—Hypertension—Capecitabine—esophageal cancer	0.0013	0.00237	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—esophageal cancer	0.00129	0.00236	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—esophageal cancer	0.00128	0.00235	CcSEcCtD
Cilostazol—Arthralgia—Capecitabine—esophageal cancer	0.00128	0.00234	CcSEcCtD
Cilostazol—Chest pain—Capecitabine—esophageal cancer	0.00128	0.00234	CcSEcCtD
Cilostazol—Myalgia—Capecitabine—esophageal cancer	0.00128	0.00234	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—esophageal cancer	0.00127	0.00233	CcSEcCtD
Cilostazol—Anxiety—Capecitabine—esophageal cancer	0.00127	0.00233	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00127	0.00232	CcSEcCtD
Cilostazol—Discomfort—Capecitabine—esophageal cancer	0.00126	0.00231	CcSEcCtD
Cilostazol—Oedema—Capecitabine—esophageal cancer	0.00122	0.00224	CcSEcCtD
Cilostazol—Infection—Capecitabine—esophageal cancer	0.00122	0.00223	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—esophageal cancer	0.00121	0.00222	CcSEcCtD
Cilostazol—Shock—Capecitabine—esophageal cancer	0.0012	0.00221	CcSEcCtD
Cilostazol—Nervous system disorder—Capecitabine—esophageal cancer	0.0012	0.0022	CcSEcCtD
Cilostazol—Thrombocytopenia—Capecitabine—esophageal cancer	0.0012	0.0022	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—esophageal cancer	0.0012	0.00219	CcSEcCtD
Cilostazol—Tachycardia—Capecitabine—esophageal cancer	0.0012	0.00219	CcSEcCtD
Cilostazol—Asthenia—Cisplatin—esophageal cancer	0.00119	0.00218	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—esophageal cancer	0.00119	0.00218	CcSEcCtD
Cilostazol—Skin disorder—Capecitabine—esophageal cancer	0.00119	0.00218	CcSEcCtD
Cilostazol—Anorexia—Capecitabine—esophageal cancer	0.00117	0.00214	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—esophageal cancer	0.00116	0.00213	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—esophageal cancer	0.00116	0.00212	CcSEcCtD
Cilostazol—Chills—Methotrexate—esophageal cancer	0.00115	0.00211	CcSEcCtD
Cilostazol—Hypotension—Capecitabine—esophageal cancer	0.00114	0.0021	CcSEcCtD
Cilostazol—Diarrhoea—Cisplatin—esophageal cancer	0.00114	0.00208	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00112	0.00204	CcSEcCtD
Cilostazol—Insomnia—Capecitabine—esophageal cancer	0.00111	0.00203	CcSEcCtD
Cilostazol—Paraesthesia—Capecitabine—esophageal cancer	0.0011	0.00201	CcSEcCtD
Cilostazol—Dyspnoea—Capecitabine—esophageal cancer	0.00109	0.002	CcSEcCtD
Cilostazol—Back pain—Methotrexate—esophageal cancer	0.00108	0.00198	CcSEcCtD
Cilostazol—Dyspepsia—Capecitabine—esophageal cancer	0.00108	0.00197	CcSEcCtD
Cilostazol—Decreased appetite—Capecitabine—esophageal cancer	0.00106	0.00195	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00106	0.00194	CcSEcCtD
Cilostazol—Vomiting—Cisplatin—esophageal cancer	0.00106	0.00193	CcSEcCtD
Cilostazol—Rash—Cisplatin—esophageal cancer	0.00105	0.00192	CcSEcCtD
Cilostazol—Pain—Capecitabine—esophageal cancer	0.00105	0.00192	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—esophageal cancer	0.00105	0.00192	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—esophageal cancer	0.00104	0.0019	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—esophageal cancer	0.00103	0.00189	CcSEcCtD
Cilostazol—Feeling abnormal—Capecitabine—esophageal cancer	0.00101	0.00185	CcSEcCtD
Cilostazol—Malaise—Methotrexate—esophageal cancer	0.00101	0.00184	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—esophageal cancer	0.001	0.00184	CcSEcCtD
Cilostazol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.001	0.00183	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—esophageal cancer	0.001	0.00183	CcSEcCtD
Cilostazol—Nausea—Cisplatin—esophageal cancer	0.000987	0.00181	CcSEcCtD
Cilostazol—Cough—Methotrexate—esophageal cancer	0.000975	0.00178	CcSEcCtD
Cilostazol—Urticaria—Capecitabine—esophageal cancer	0.000973	0.00178	CcSEcCtD
Cilostazol—Body temperature increased—Capecitabine—esophageal cancer	0.000968	0.00177	CcSEcCtD
Cilostazol—Abdominal pain—Capecitabine—esophageal cancer	0.000968	0.00177	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—esophageal cancer	0.000951	0.00174	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—esophageal cancer	0.000951	0.00174	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—esophageal cancer	0.000951	0.00174	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000944	0.00173	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—esophageal cancer	0.000939	0.00172	CcSEcCtD
Cilostazol—Infection—Methotrexate—esophageal cancer	0.000906	0.00166	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—esophageal cancer	0.000894	0.00164	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—esophageal cancer	0.000892	0.00163	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—esophageal cancer	0.000885	0.00162	CcSEcCtD
Cilostazol—Asthenia—Capecitabine—esophageal cancer	0.000878	0.00161	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—esophageal cancer	0.000869	0.00159	CcSEcCtD
Cilostazol—Pruritus—Capecitabine—esophageal cancer	0.000866	0.00159	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—esophageal cancer	0.000852	0.00156	CcSEcCtD
Cilostazol—Diarrhoea—Capecitabine—esophageal cancer	0.000838	0.00153	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00083	0.00152	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—esophageal cancer	0.000824	0.00151	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—esophageal cancer	0.000818	0.0015	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—esophageal cancer	0.000813	0.00149	CcSEcCtD
Cilostazol—Dizziness—Capecitabine—esophageal cancer	0.00081	0.00148	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—esophageal cancer	0.000802	0.00147	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—esophageal cancer	0.000792	0.00145	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000787	0.00144	CcSEcCtD
Cilostazol—Pain—Methotrexate—esophageal cancer	0.000779	0.00143	CcSEcCtD
Cilostazol—Vomiting—Capecitabine—esophageal cancer	0.000779	0.00143	CcSEcCtD
Cilostazol—Rash—Capecitabine—esophageal cancer	0.000772	0.00141	CcSEcCtD
Cilostazol—Dermatitis—Capecitabine—esophageal cancer	0.000771	0.00141	CcSEcCtD
Cilostazol—Headache—Capecitabine—esophageal cancer	0.000767	0.0014	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—esophageal cancer	0.000751	0.00138	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000745	0.00137	CcSEcCtD
Cilostazol—Nausea—Capecitabine—esophageal cancer	0.000727	0.00133	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—esophageal cancer	0.000724	0.00133	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—esophageal cancer	0.000721	0.00132	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—esophageal cancer	0.000721	0.00132	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—esophageal cancer	0.000654	0.0012	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—esophageal cancer	0.000645	0.00118	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—esophageal cancer	0.000624	0.00114	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—esophageal cancer	0.000603	0.0011	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—esophageal cancer	0.00058	0.00106	CcSEcCtD
Cilostazol—Rash—Methotrexate—esophageal cancer	0.000575	0.00105	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—esophageal cancer	0.000574	0.00105	CcSEcCtD
Cilostazol—Headache—Methotrexate—esophageal cancer	0.000571	0.00105	CcSEcCtD
Cilostazol—Nausea—Methotrexate—esophageal cancer	0.000541	0.000992	CcSEcCtD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000283	0.000624	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—XIAP—esophageal cancer	0.000282	0.000622	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.00028	0.000617	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CA2—esophageal cancer	0.000279	0.000614	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CTNNA1—esophageal cancer	0.000267	0.000588	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCL2—esophageal cancer	0.000265	0.000585	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000259	0.00057	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000259	0.00057	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000259	0.00057	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000259	0.00057	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000258	0.000569	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PSME1—esophageal cancer	0.000248	0.000546	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PSME2—esophageal cancer	0.000248	0.000546	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ANXA1—esophageal cancer	0.000247	0.000544	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SST—esophageal cancer	0.00024	0.000529	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000238	0.000525	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—EP300—esophageal cancer	0.000237	0.000521	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000235	0.000518	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH3—esophageal cancer	0.000234	0.000515	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GHRL—esophageal cancer	0.000234	0.000515	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FBXW7—esophageal cancer	0.00023	0.000507	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000227	0.0005	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000225	0.000496	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000224	0.000493	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000221	0.000487	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CA1—esophageal cancer	0.00022	0.000485	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.00022	0.000485	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000217	0.000478	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000211	0.000465	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH2—esophageal cancer	0.00021	0.000462	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000206	0.000453	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CA2—esophageal cancer	0.000201	0.000444	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000201	0.000443	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.0002	0.000441	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.0002	0.000441	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000196	0.000432	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000196	0.000432	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000188	0.000414	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000187	0.000412	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000187	0.000412	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFBR2—esophageal cancer	0.000186	0.00041	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000184	0.000406	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000184	0.000406	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000181	0.000399	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.000179	0.000395	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000179	0.000394	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SMAD4—esophageal cancer	0.000176	0.000388	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000175	0.000387	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PIK3CA—esophageal cancer	0.000175	0.000386	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GNG7—esophageal cancer	0.000171	0.000376	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CA1—esophageal cancer	0.00017	0.000375	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.00017	0.000375	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—esophageal cancer	0.000169	0.000373	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000164	0.000362	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.00016	0.000352	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000157	0.000346	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000157	0.000345	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CA1—esophageal cancer	0.000157	0.000345	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000156	0.000344	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000156	0.000344	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CA2—esophageal cancer	0.000156	0.000343	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000153	0.000336	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000152	0.000335	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000152	0.000335	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.00015	0.000331	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000149	0.000328	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000145	0.000319	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000145	0.000319	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HIF1A—esophageal cancer	0.000144	0.000318	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CA2—esophageal cancer	0.000143	0.000315	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000143	0.000315	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000143	0.000314	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000143	0.000314	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000142	0.000312	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000142	0.000312	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000141	0.000309	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000141	0.000309	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000139	0.000307	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KDR—esophageal cancer	0.000138	0.000304	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000136	0.0003	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000133	0.000293	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000133	0.000293	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CA1—esophageal cancer	0.000133	0.000292	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000133	0.000292	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000131	0.000288	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOTCH1—esophageal cancer	0.00013	0.000286	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.00013	0.000286	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000127	0.00028	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000123	0.000272	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CA2—esophageal cancer	0.000121	0.000267	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000121	0.000267	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.000121	0.000267	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.00012	0.000265	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.00012	0.000265	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000119	0.000261	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000118	0.00026	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CREBBP—esophageal cancer	0.000118	0.000259	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000117	0.000257	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EGFR—esophageal cancer	0.000116	0.000255	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000116	0.000255	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.000115	0.000253	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.000114	0.000251	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000113	0.000248	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000113	0.000248	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000112	0.000246	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000111	0.000246	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000111	0.000244	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.00011	0.000242	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTO1—esophageal cancer	0.00011	0.000242	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TPI1—esophageal cancer	0.00011	0.000242	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000109	0.000239	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000109	0.000239	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000106	0.000233	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NOS3—esophageal cancer	0.000105	0.000232	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDOB—esophageal cancer	0.000105	0.000232	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HMOX1—esophageal cancer	0.000104	0.000229	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000103	0.000227	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000103	0.000227	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000102	0.000225	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA1—esophageal cancer	0.000102	0.000225	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSME1—esophageal cancer	0.000102	0.000224	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PSME2—esophageal cancer	0.000102	0.000224	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GAPDH—esophageal cancer	0.000101	0.000223	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000101	0.000222	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000101	0.000222	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—PIK3CA—esophageal cancer	0.0001	0.000221	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CRABP1—esophageal cancer	0.0001	0.000221	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.98e-05	0.00022	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADH1B—esophageal cancer	9.89e-05	0.000218	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB2—esophageal cancer	9.86e-05	0.000217	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDOB—esophageal cancer	9.67e-05	0.000213	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GNG7—esophageal cancer	9.54e-05	0.00021	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TYMP—esophageal cancer	9.45e-05	0.000208	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CA2—esophageal cancer	9.36e-05	0.000206	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GAPDH—esophageal cancer	9.31e-05	0.000205	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.23e-05	0.000203	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP26A1—esophageal cancer	9.19e-05	0.000202	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALOX15—esophageal cancer	8.96e-05	0.000197	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDH2—esophageal cancer	8.94e-05	0.000197	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GNG7—esophageal cancer	8.78e-05	0.000193	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.76e-05	0.000193	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—esophageal cancer	8.71e-05	0.000192	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.7e-05	0.000192	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADH7—esophageal cancer	8.7e-05	0.000192	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTO1—esophageal cancer	8.55e-05	0.000188	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TPI1—esophageal cancer	8.55e-05	0.000188	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—esophageal cancer	8.5e-05	0.000187	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1A—esophageal cancer	8.43e-05	0.000186	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2A6—esophageal cancer	8.41e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.37e-05	0.000184	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP19A1—esophageal cancer	8.24e-05	0.000182	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.22e-05	0.000181	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDOB—esophageal cancer	8.19e-05	0.00018	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EP300—esophageal cancer	8.02e-05	0.000177	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS1—esophageal cancer	7.97e-05	0.000176	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO1—esophageal cancer	7.97e-05	0.000176	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GAPDH—esophageal cancer	7.89e-05	0.000174	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSME1—esophageal cancer	7.85e-05	0.000173	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PSME2—esophageal cancer	7.85e-05	0.000173	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.82e-05	0.000172	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CRABP1—esophageal cancer	7.82e-05	0.000172	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.73e-05	0.00017	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.63e-05	0.000168	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.52e-05	0.000166	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GNG7—esophageal cancer	7.43e-05	0.000164	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO1—esophageal cancer	7.33e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.33e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TYMP—esophageal cancer	7.29e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSME1—esophageal cancer	7.22e-05	0.000159	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PSME2—esophageal cancer	7.22e-05	0.000159	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—esophageal cancer	7.22e-05	0.000159	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.09e-05	0.000156	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—esophageal cancer	6.99e-05	0.000154	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDH2—esophageal cancer	6.97e-05	0.000153	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.91e-05	0.000152	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.86e-05	0.000151	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—esophageal cancer	6.84e-05	0.000151	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1B1—esophageal cancer	6.78e-05	0.000149	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.67e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—esophageal cancer	6.63e-05	0.000146	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.59e-05	0.000145	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TPI1—esophageal cancer	6.59e-05	0.000145	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2A6—esophageal cancer	6.55e-05	0.000144	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.52e-05	0.000144	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.37e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.32e-05	0.000139	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.23e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO1—esophageal cancer	6.21e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS1—esophageal cancer	6.21e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSME2—esophageal cancer	6.12e-05	0.000135	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PSME1—esophageal cancer	6.12e-05	0.000135	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.09e-05	0.000134	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.03e-05	0.000133	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NOS3—esophageal cancer	5.97e-05	0.000132	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—esophageal cancer	5.93e-05	0.000131	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.86e-05	0.000129	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.81e-05	0.000128	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—esophageal cancer	5.74e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GNG7—esophageal cancer	5.74e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.7e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.58e-05	0.000123	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.46e-05	0.00012	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.38e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.35e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.34e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.28e-05	0.000116	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.13e-05	0.000113	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.11e-05	0.000113	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.05e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP19A1—esophageal cancer	4.96e-05	0.000109	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.82e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.79e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO1—esophageal cancer	4.79e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSME2—esophageal cancer	4.72e-05	0.000104	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PSME1—esophageal cancer	4.72e-05	0.000104	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—EP300—esophageal cancer	4.54e-05	0.0001	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HMOX1—esophageal cancer	4.53e-05	9.98e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.44e-05	9.79e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.35e-05	9.58e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NOS3—esophageal cancer	4.32e-05	9.51e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.22e-05	9.29e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.07e-05	8.97e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.95e-05	8.7e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.83e-05	8.44e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.73e-05	8.21e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.5e-05	7.7e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.43e-05	7.55e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.36e-05	7.41e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.36e-05	7.39e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NOS3—esophageal cancer	3.34e-05	7.35e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.29e-05	7.24e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—EP300—esophageal cancer	3.29e-05	7.24e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NOS3—esophageal cancer	3.07e-05	6.76e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.05e-05	6.73e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.91e-05	6.4e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.81e-05	6.19e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NOS3—esophageal cancer	2.6e-05	5.73e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—EP300—esophageal cancer	2.54e-05	5.59e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.43e-05	5.35e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.38e-05	5.24e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—EP300—esophageal cancer	2.34e-05	5.15e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.24e-05	4.94e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NOS3—esophageal cancer	2.01e-05	4.42e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—EP300—esophageal cancer	1.98e-05	4.36e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.88e-05	4.14e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.84e-05	4.04e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.73e-05	3.81e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EP300—esophageal cancer	1.53e-05	3.36e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.46e-05	3.22e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.13e-05	2.49e-05	CbGpPWpGaD
